Scarica l'app Stockscreener
18.79
2.94%
-0.57
Arcus Biosciences Inc Azioni (RCUS) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
141.18%
41.00
|
17.00 | 33.00 | 26.00 | 160.00 |
| Operating Expenses |
9.27%
137.00
|
151.00 | 147.00 | 168.00 | 168.00 |
| Depreciation and Amortization |
50.00%
3.00
|
2.00 | 3.00 | 2.00 | 2.00 |
| Operating Income/Loss |
28.36%
-96.00
|
-134.00 | -114.00 | -142.00 | -8.00 |
| Nonoperating Income/Loss |
16.67%
5.00
|
6.00 | 8.00 | 7.00 | 8.00 |
| Income/Loss From Continuing Operations Before Tax |
28.91%
-91.00
|
-128.00 | -106.00 | -135.00 | - |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Net Income/Loss |
28.91%
-91.00
|
-128.00 | -106.00 | -135.00 | - |
| Basic Average Shares |
0.56%
126.10
|
125.40 | 3.70 | 106.50 | 106.10 |
| Diluted Average Shares |
0.56%
126.10
|
125.40 | 3.70 | 106.50 | 106.50 |
| Basic Earnings Per Share |
29.41%
-0.72
|
-1.02 | -0.90 | -1.27 | - |
| Diluted Earnings Per Share |
29.41%
-0.72
|
-1.02 | -0.90 | -1.27 | - |
2.65%
0.26%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):